To define the composition of the vaginal microbiome in healthy and pregnant women, a number of large clinical studies have now been initiated by the Center for Translational Microbiome Research (CTMR) in collaboration with Uppsala University Hospital. CTMR started in January 2016 as collaboration between SciLifeLab, KI and the Swiss company Ferring Pharmaceuticals to establish a broad technical, biological, clinical and epidemiological platform for studying microbial communities in humans in the area of gastroenterology and reproductive health.
Last week, recruitment started in VaMiGyn (Vaginal microbiome and gynecological health). The study recruits 2500 women and collects microbiome samples from the mouth, gut and vagina together with clinical metadata.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.